These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7419274)

  • 61. Data on sisomicin effect: human pharmacokinetic and bacteriological studies.
    Faragó E; Kiss IJ; Mihóczy L
    Int J Clin Pharmacol Ther Toxicol; 1980 Mar; 18(3):128-32. PubMed ID: 7380585
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Sisomicin: a review of eight years' experience.
    Sanders WE; Sanders CC
    Rev Infect Dis; 1980; 2(2):182-95. PubMed ID: 6994206
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Binding of sisomicin and gentamicin to serum proteins (author's transl)].
    Rosenkranz H; Scheer M; Scholtan W
    Arzneimittelforschung; 1976; 26(8):1517-21. PubMed ID: 1036948
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Clinical trial of the antibiotic Sisomycin].
    Mariani B; Mancini P
    G Ital Chemioter; 1977; 24(1-2):127-30. PubMed ID: 615756
    [No Abstract]   [Full Text] [Related]  

  • 65. Uptake of (methyl-14C)-sisomicin and (methyl-14C)-gentamicin into bacterial cells.
    Lee BK; Condon RG; Munayyer H; Weinstein MJ
    J Antibiot (Tokyo); 1978 Feb; 31(2):141-6. PubMed ID: 416011
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparative study of three routes of administration of sisomicin.
    Meunier-Carpentier F; Staquet M; Klastersky J
    J Clin Pharmacol; 1976; 16(11-12):625-30. PubMed ID: 993357
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparison of four aminoglycoside antibiotics in the therapy of experimental E. coli meningitis.
    Strausbaugh LJ; Mandaleris CD; Sande MA
    J Lab Clin Med; 1977 Apr; 89(4):692-701. PubMed ID: 321713
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Treatment of acute pelvic inflammatory diseases with a new antibiotic compound preparation (author's transl)].
    Burmucic R
    Wien Med Wochenschr; 1980 Nov; 130(22):744-9. PubMed ID: 7467388
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Netilmicin pharmacokinetics after single intravenous doses to elderly male patients.
    Welling PG; Baumueller A; Lau CC; Madsen PO
    Antimicrob Agents Chemother; 1977 Sep; 12(3):328-34. PubMed ID: 907325
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Use of aminoglycosides in surgical infections.
    Stone HH; Kolb LD; Geheber CE; Dawkins EJ
    Ann Surg; 1976 Jun; 183(6):660-6. PubMed ID: 973753
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Efficacy and pharmacokinetics of Timentin in paediatric infections.
    Bégué P; Quiniou F; Quinet B
    J Antimicrob Chemother; 1986 May; 17 Suppl C():81-91. PubMed ID: 3636339
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Transfer of sisomicin to unborn and suckling guinea pigs.
    Matsuzawa T; Nakata M; Ikeda C; Tachibana A; Yano K
    Chemotherapy; 1981; 27(5):297-302. PubMed ID: 7261685
    [TBL] [Abstract][Full Text] [Related]  

  • 73. ["In vitro" activity of gentamicin, sisomicin and tobramycin against "pseudomonas aeruginosa" strains from hospital sources (author's transl)].
    Campello C; Crevatin E
    Ann Sclavo; 1977; 19(3):437-45. PubMed ID: 415672
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Build up of a given concentration of tobramycin and sisomycin in the blood of young children by the intravenous infusion of the antibiotics according to a calculated regimen].
    Firsov AA; Pankova GF
    Antibiotiki; 1982 Nov; 27(11):830-5. PubMed ID: 6758682
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Human pharmacology of 5-epi-sisomicin (Sch 22591) following intramuscular administration.
    Blaser J; Münch R; Lüthy R
    J Antimicrob Chemother; 1987 Feb; 19(2):233-8. PubMed ID: 3571044
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A comparative trial of sisomicin therapy by intermittent versus continuous infusion.
    Feld R; Valdivieso M; Bodey GP; Rodriguez V
    Am J Med Sci; 1977; 274(2):179-88. PubMed ID: 602958
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Evaluation of the therapeutic effectiveness and tolerability of sisomicin in the treatment of urinary tract infections].
    Dall'Aglio P; Nardoni N
    Clin Ter; 1980 Mar; 92(6):603-11. PubMed ID: 7460489
    [No Abstract]   [Full Text] [Related]  

  • 78. [Complicated infections of the urinary tract. Antibacterial therapy with twice daily sisomicin (author's transl)].
    Prát V; Bohuslav V; Hatala M; Liska M
    Cas Lek Cesk; 1978 Dec; 111(50):1553-7. PubMed ID: 737680
    [No Abstract]   [Full Text] [Related]  

  • 79. Treatment with sisomicin of complicated urinary tract infections in patients with varying degrees of renal function impairment, pharmacokinetics and dosage adjustment.
    Mosegaard A; Welling PG; Tse FL; Madsen P
    Infection; 1975; 3(3):143-7. PubMed ID: 1223005
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The combined action of azlocillin and sisomicin in a model simulating the in vivo serum kinetics.
    Haller I
    Infection; 1983; 11 Suppl 2():S81-2. PubMed ID: 6423547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.